Previous Meetings

GBCC 2015

Global Breast Cancer Conference 2015

07:30-08:10
Breakfast Symposium 2 (Sponsored by Novartis)
Venue: Halla Hall
  • The Role of The Everolimus in the Treatment Landscape for ER+ Advanced Breast Cancer Patients
    Fabrice Andre (Breast Cancer Unit, Institut Gustave Roussy, France)
08:30-09:30
Plenary Lecture 5
Venue: Halla Hall
  • Development of Multinational Breast Cancer Data Base: Strategy and Challenge
    Byung Ho Nam (Center for Clinical Trials, National Cancer Center, Korea)
Survivorship Session 1
Cohort Study in Breast Cancer Survivor
Venue: Lotus Hall
  • Breast Cancer Survivor Study from the Shanghai Women’s Health Study
    Wei Zheng (Division of Epidemiology, Vanderbilt Univ. School of Medicine, U.S.A.)
  • The Pathways Study: a Prospective Study of Breast Cancer Survivorship
    Janise M. Kim Roh (Division of Research, Kaiser Permanente Northern California, U.S.A.)
  • Breast Cancer Survivors in Korea: Today and Tomorrow
    So-Youn Jung (Department of Surgery, Center of Breast Cancer, National Cancer Center, Korea)
09:40-10:40
Survivorship Session 2
Recent Update of Breast Cancer Survivor Research
Venue: Lotus Hall
  • Nutrition for Breast Cancer Survivors
    Jung Eun Lee (Department of Food & Nutrition, Sookmyung Women’s Univ., Korea)
  • Breast Cancer Survivorship: Cultural and Socio-ecologic Considerations
    Kimlin Tam Ashing (Department of Population Sciences, City of Hope Comprehensive Cancer Center, U.S.A.)
  • Targeting Distress during the Treatment of Breast Cancer Survivors
    Jong Won Lee (Department of Surgery, Division of Breast and Endocrine Surgery, ASAN Medical Center, Korea)
09:40-10:50
Symposium 8
Tumor Registry
Venue: Halla Hall
  • Breast Cancer in the Gulf: Building an Integrated Registry
    Shaheenah Dawood (Consultant Medical Oncologist, Dubai Hospital, U.A.E.)
  • National Clinical Database - Breast Cancer Registry in Japan
    Reiko Yoshida (Breast Center, Showa Univ., Japan)
  • From Institutional to Territory-wide Breast Cancer Registry - The Hong Kong Experience
    Roger Kai Cheong Ngan (Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong)
Oral Presentation 3
Venue: Weolla Room
  • [OP3-1] A NOVEL POTENTIAL PROGNOSTIC MARKER SIRT1 ON TUMOR INVASION AND METASTASIS, AND TUMOR RECURRENCE IN TRIPLE NEGATIVE BREAST CANCER
    Han Suk Ryu (Department of Pathology, Seoul National Univ. Hospital, Korea)
  • [OP3-2] OPPOSING ROLE OF MIRNA-155 IN TUMOR MICROENVIRONMENT AND TUMOR CELLS COMPENSATE EACH OTHER IN MOUSE BREAST CANCER MODEL
    Suhwan Chang (Department of Biomedical Sciences, UUCM, ASAN Medical Center, Korea)
  • [OP3-3] MITOCHONDRIAL ERβ INTERACTING WITH HSP70, ENHANCES THE ANTI-CANCER ACTIVITY OF TAMOXIFEN VIA IMPROVEMENT OF MITOCHONDRIAL FUNCTION IN BREAST CANCER
    Hyung Joo Baik (Department of Surgery, Busan Paik Hospital, Inje Univ., Korea)
  • [OP3-4] EXPLORATION OF MOLECULAR MARKER CANDIDATES PREDICTING AXILLARY LYMPH NODE METASTASIS BY CAP ANALYSIS OF GENE EXPRESSION
    Hyonmi Sai (Division of Breast Oncology, Juntendo Univ. School of Medicine, Japan)
  • [OP3-5] SYNERGISTIC INDUCTION OF APOPTOSIS BY DCA AND S6K1 INHIBITION IN BREAST CANCER CELLS VIA DOWNREGULATION OF HK2
    Sung-Eun Hong (Division of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Korea)
  • [OP3-6] LYN PLAYS AN IMPORTANT ROLE IN ACQUIRING TAMOXIFEN-RESISTANCE ON MCF7 BREAST CANCER CELLS
    Sung-Keum Seo (Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Korea)
  • [OP3-7] PROGESTERONE RECEPTOR-LACKING TUMOR IN HORMONE RECEPTOR-POSITIVE AND HER2-NEGATIVE BREAST CANCER: HIGH RATE OF TP53 MUTATION AND INCREASED GLYCOLYTIC ACTIVITY
    Sung Gwe Ahn (Department of Surgery, Gangnam Severance Hospital, Yonsei Univ. College of Medicine, Korea)
  • [OP3-8] ESTABLISHMENT AND CHARACTERIZATION OF PATIENT-DERIVED HUMAN BREAST CANCER XENOGRAFT MODELS
    Jeong Eon Lee (Department of Surgery, Samsung Medical Center, Korea)
10:50-12:00
Symposium 9
Issues in the Management of Asian Countries
Venue: Halla Hall
  • Transformation of Breast Cancer in Taiwan
    Chiun-Sheng Huang (Department of Surgery, National Taiwan Univ. Hospital, Taiwan)
  • Restricted Access to Medical Resources in Underdeveloped Countries
    Thinh Dang Huy Quoc (Department of Radiation Oncology, Ho Chi Minh City Oncology Hospital, Viet Nam)
  • Onco-fertility
    Chikako Shimizu (Department of Breast and Medical Oncology, National Cancer Center, Japan)
Education Session 3
Career Development
Venue: Lotus Hall
  • How to Write a Good Research Grant Proposal
    Fabrice Andre (Breast Cancer Unit, Institut Gustave Roussy, France)
  • Career Development as a Junior Researcher
    Daniel F. Hayes (Internal Medicine, Hematology Oncology, Univ. of Michigan Comprehensive Cancer Center, U.S.A.)
  • How to Succeed as a Private Breast Practitioner in Korea
    Heeboong Park (Breast Clinic, Park Surgical Clinic, Korea)
  • How to Build and Maintain the Multinational Network
    Vani Parmar (Department of Surgical Oncology, Tata Memorial Hospital, India)
Oral Presentation 4
Venue: Weolla Room
  • [OP4-1] THE TRANSITION TO NEXT GENERATION SEQUENCING FROM CONVENTIONAL SANGER SEQUENCING FOR BREAST CANCER GENETIC STUDY
    Tsun Leung Chan (Department of Pathology, Hong Kong Sanatorium and Hospital, Hong Kong)
  • [OP4-2] CLINICAL APPLICATION OF COLOR MAP PATTERN ON SHEAR WAVE ELASTOGRAPHY (SWE) IN INVASIVE BREAST CANCER
    Seokwon Lee (Department of Surgery, Biomedical Research Institute, Pusan National Univ. Hospital, Korea)
  • [OP4-3] HYPERBARIC OXYGEN TREATMENT IN REDUCING SIDE-EFFECTS OF RADIATION THERAPY OF THE BREAST
    David Teguh (Department of Hyperbaric Medicine, Academic Medical Center, Univ. of Amsterdam, Netherlands)
  • [OP4-4] THE BASIC FACTS OF KOREAN BREAST CANCER IN 2012: RESULTS OF A NATIONWIDE SURVEY AND BREAST CANCER REGISTRY DATABASE
    Min Hee Hur (Department of Surgery, Cheil General Hospital and Women’s Healthcare Center, Kwandong Univ. College of Medicine, Korea)
  • [OP4-5] WHO ARE SEXUALLY ACTIVE DURING AND AFTER BREAST CANCER TREATMENT? PATTERNS OF SEXUAL FUNCTIONING CHANGES IN BREAST CANCER PATIENTS FROM DIAGNOSIS TO 3 YEAR FOLLOW-UP
    Danbee Kang (Department of Health Science and Technology, SAHIST, Sungkyunkwan Univ., Korea)
  • [OP4-6] PROSPECTIVE STUDY OF INTERNAL MAMMARY SENTINEL LYMPH NODE BIOPSY IN PATIENTS WITH CLINICALLY POSITIVE AXILLARY LYMPH NODES
    Yongsheng Wang (Breast Cancer Center, Shandong Cancer Hospital and Institute, China)
  • [OP4-7] BREAST-SPECIFIC GAMMA IMAGING VERSUS MAGNETIC RESONANCE IMAGING IN DUCTAL CARCINOMA IN SITU: A PROSPECTIVE HEAD-TO-HEAD TRIAL
    Beom Seok Ko (Department of Surgery, Univ. of Ulsan College of Medicine, ASAN Medical Center, Korea)
  • [OP4-8] DEPRESSION AND ANXIETY AFTER ADJUVANT OVARIAN SUPPRESSION IN PREMENOPAUSAL BREAST CANCER
    Ha Woo Yi (Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Korea)
Back to Previous Meetings